it hurt to move my arm, now it's gone; heat at the site of injection; swelling at the site of injection; itching at the site of injection; hardness at the site of injection; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical history Information was reported.  Concomitant products included OMEPRAZOLE, SERTRALINE, UBIDECARENONE (COQ-10), TOPIRAMATE, NORTRIPTYLINE, RIBOFLAVIN, CYANOCOBALAMIN (VITAMIN B-12) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 13-May-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection). At the time of the report, VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information for the event was provided. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 21-May-2021 and was forwarded to Moderna on 21-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038C21A) for COVID-19 vaccination.     No Medical history Information was reported.  Concomitant products included OMEPRAZOLE, SERTRALINE, UBIDECARENONE (COQ-10), TOPIRAMATE, NORTRIPTYLINE, RIBOFLAVIN, CYANOCOBALAMIN (VITAMIN B-12) and MULTIVITAMIN [VITAMINS NOS] for an unknown indication.    On 13-May-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection). At the time of the report, VACCINATION SITE PAIN (it hurt to move my arm, now it's gone), VACCINATION SITE WARMTH (heat at the site of injection), VACCINATION SITE SWELLING (swelling at the site of injection), VACCINATION SITE PRURITUS (itching at the site of injection) and VACCINATION SITE INDURATION (hardness at the site of injection) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information for the event was provided.